stockrowBionano Genomics, Inc. (BNGO) vs Harvard Bioscience, Inc. (HBIO)
- Bionano Genomics, Inc. BNGO 1.11 −6.72%
- Harvard Bioscience, Inc. HBIO 8.55 −0.70%
Bionano Genomics, Inc. and Harvard Bioscience, Inc. are both Medical Instruments & Supplies companies. Harvard Bioscience, Inc. is the larger, with a market value of $38.5M against $15.4M — 2.5× the size. Bionano Genomics, Inc. grew revenue faster over the last twelve months: 10.0% against −1.06%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −106.6%) and the higher return on invested capital (−0.41% vs −81.7%). Across the 18 metrics below, Bionano Genomics, Inc. leads on 10 and Harvard Bioscience, Inc. on 8.
Valuation
Profitability
| Metric | BNGO | HBIO | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 47.51% | 58.16% | 53.60% |
| Operating margin | (106.67%) | (0.28%) | 1.97% |
| Net margin | (106.58%) | (11.86%) | 0.00% |
| Free cash flow margin | (67.87%) | (2.09%) | 2.36% |
| Return on equity | (83.56%) | (89.95%) | 0.00% |
| Return on assets | (52.04%) | (13.32%) | 0.00% |
| Return on invested capital | (81.68%) | (0.41%) | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack